Schroth and Pilates for Adolescent Idiopathic Scoliosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorAnkara Yildirim Beyazıt University
About this trial
The primary aim of this study is to investigate the effectiveness of Schroth training and the multidimensional effects of adding Pilates-based exercises to Schroth training in individuals with adolescent idiopathic scoliosis. Specifically, the study aims to evaluate the effects of Pilates-based exercises combined with Schroth training on lung capacity, trunk muscle strength, proprioception, trunk rotation, and posture. In addition, it seeks to examine the impact of the intervention on important functional and psychosocial outcomes, including quality of life, perceived cosmetic deformity, and pain threshold.
This study is expected to contribute to the existing evidence on the use of Pilates exercises in combination with Schroth exercises for individuals with adolescent idiopathic scoliosis by providing a comprehensive evaluation of the effects of this combined intervention. The findings are intended to provide guidance for clinicians and researchers regarding the combined use of different exercise approaches in the management of adolescent idiopathic scoliosis. Furthermore, the study aims to explore the potential benefits of integrating the Schroth method with Pilates as a holistic treatment approach for scoliosis management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 10-18 years.
Diagnosed with adolescent idiopathic scoliosis by a physician.
Cobb angle between 10° and 45°.
Willingness of both the participant and their parent/legal guardian to participate in the study.
Disqualifiers
History of scoliosis or spinal surgery.
Scoliosis secondary to neurological, congenital, or other non-idiopathic causes.
Any contraindication to exercise.
A spinal curve with an apex at T12-L1.
Trial design
Design model
Parallel
Treatments tested in this trial
Schroth Group
BehavioralParticipants will be randomly allocated to either the intervention group or the control group.Participants in the control group will receive supervised Schroth exercise training twice weekly for 8 weeks in face-to-face sessions conducted by a physiotherapist. In addition, they will perform only the Schroth home exercise program.All participants will perform their home exercises twice daily, in the morning and evening. Before prescribing the home exercise program, the physiotherapist will provide detailed instructions and demonstrate each exercise during the clinical sessions. The home exercises will be performed twice daily, with each exercise consisting of 3 sets of 10 repetitions.
Schroth and Pilates Group
Other interventionParticipants will be randomly allocated to either the intervention group or the control group. Participants in the intervention group will receive supervised Schroth training combined with Pilates-based exercises twice weekly for 8 weeks in face-to-face sessions conducted by a physiotherapist. In addition, they will be prescribed a home exercise program consisting of Schroth home exercises and Pilates-based exercises.All participants will perform their home exercises twice daily, in the morning and evening. Before prescribing the home exercise program, the physiotherapist will provide detailed instructions and demonstrate each exercise during the clinical sessions. The home exercises will be performed twice daily, with each exercise consisting of 3 sets of 10 repetitions.
Treatment groups
34 Participants
are divided into 2 treatment groupsGroup A: Schroth GroupActive comparator 1 intervention
Group B: Schroth Combined with Pilates GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Assessment of Lung Capacity
Vital Capacity (VC) will be assessed using a COSMED microQuark PC spirometer (Rome, Italy). During the assessment, participants will be seated comfortably in an upright position. A nose clip will be applied to prevent airflow through the nose during the test. VC values will be interpreted by comparing the measured values with the predicted reference values obtained from healthy individuals.
Time frame
Baseline and 2 months2
Assessment of Lung Capacity
Forced Vital Capacity (FVC) will be assessed using a COSMED microQuark PC spirometer (Rome, Italy). During the assessment, participants will be seated comfortably in an upright position. A nose clip will be applied to prevent airflow through the nose during the test. FVC values will be interpreted by comparing the measured values with the predicted reference values obtained from healthy individuals.
Time frame
Baseline and 2 months3
Assessment of Lung Capacity
Total Lung Capacity (TLC) will be assessed using a COSMED microQuark PC spirometer (Rome, Italy). During the assessment, participants will be seated comfortably in an upright position. A nose clip will be applied to prevent airflow through the nose during the test. TLC values will be interpreted by comparing the measured values with the predicted reference values obtained from healthy individuals.
Time frame
Baseline and 2 months4
Assessment of Lung Capacity
Residual Volume (RV) will be assessed using a COSMED microQuark PC spirometer (Rome, Italy). During the assessment, participants will be seated comfortably in an upright position. A nose clip will be applied to prevent airflow through the nose during the test. RV values will be interpreted by comparing the measured values with the predicted reference values obtained from healthy individuals.
Time frame
Baseline and 2 monthsSecondary outcomes
1
Assessment of Quality of Life
Quality of life will be assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire. The Turkish validity and reliability of the questionnaire were established by Alanay et al. (2005). The SRS-22 consists of 22 items organized into five domains: pain, self-image/appearance, function/activity, mental health, and satisfaction with treatment. Each item is scored on a 5-point Likert scale, with higher scores indicating better quality of life. Permission to use the questionnaire will be obtained following ethics committee approval.
Time frame
Baseline and 2 months2
Assessment of Perceived Cosmetic Deformity
Perceived cosmetic deformity will be assessed using the Walter Reed Visual Assessment Scale (WRVAS). The Turkish validity and reliability of the scale were established by Çolak et al. (2020). The WRVAS is a visual instrument developed to evaluate how individuals with adolescent idiopathic scoliosis perceive their own deformity. It consists of seven items assessing spinal deformity, rib prominence, lumbar prominence, thoracic deformity, trunk imbalance, shoulder asymmetry, and scapular asymmetry. Each item includes five illustrations representing increasing deformity severity and is scored from 1 to 5, with higher scores indicating greater perceived deformity. The questionnaire will be completed separately by the physiotherapist, the participant, and a parent before and after the intervention. Permission to use the scale will be obtained following ethics committee approval.
Time frame
Baseline and 2 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov